Related Experiment Video
Updated: Mar 19, 2026
08:50
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
1.1K
Bariatric surgery for obesity-associated decline in kidney function: filling the knowledge gap?
Varun Agrawal1, Sankar D Navaneethan2
1Division of Nephrology and Hypertension, University of Vermont, Burlington, Vermont, USA.
Kidney International
|June 18, 2016
Summary
Bariatric surgery may lower the risk of kidney function decline in obese adults. However, limitations in study data and kidney function measurement require careful consideration of risks versus benefits for patients with kidney disease.
Area of Science:
- Nephrology
- Bariatric Surgery
- Obesity Medicine
Background:
- Obesity is a significant risk factor for chronic kidney disease.
- Bariatric surgery is an effective weight-loss intervention for obese individuals.
- The impact of bariatric surgery on kidney function decline requires further investigation.
Purpose of the Study:
- To evaluate the effect of bariatric surgery on the decline of estimated glomerular filtration rate (eGFR) in obese adults.
- To compare the risk of kidney function decline in surgically treated obese adults versus a matched nonsurgical cohort.
Main Methods:
- Propensity-matched analysis comparing obese adults who underwent bariatric surgery with a similar nonsurgical group.
- Assessment of estimated glomerular filtration rate (eGFR) as a measure of kidney function.
Main Results:
- A significantly lower risk of eGFR decline was observed in the bariatric surgery group compared to the nonsurgical cohort.
- The study acknowledges limitations including missing data on confounding variables and the accuracy of creatinine-based eGFR after significant weight loss.
Conclusions:
- Bariatric surgery may be associated with a reduced risk of kidney function decline in obese adults.
- Physicians should carefully weigh the benefits and risks of bariatric surgery for obese patients at risk of kidney disease, considering study limitations.
Related Concept Videos
01:21Drug Dosing: Obese Patients
332
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
332
01:26Kidney Transplant II: Surgical Procedure
718
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
718
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
358
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
358
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
269
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
269
01:28Kidney Transplant I: Introduction
666
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
666
01:16Kidney Transplant III: Nursing Management
534
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
534